Research co-led by a
St. Jude investigator and researchers from Columbia University and the New York State Psychiatric Institute reveals the mechanics of how some transporter proteins function with stunning specificity.
This holiday season, Jennifer Aniston, Sofia Vergara, Michael Strahan, Luis Fonsi, Brad Paisley and many more celebrities will join
St. Jude Children’s Research Hospital® National Outreach Director Marlo Thomas in supporting the annual
Thanks and Giving® campaign.
An International collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse.
St. Jude Children’s Research Hospital announces the return of its annual holiday season
Thanks and Giving® campaign, asking shoppers from all over the country to donate through their favorite in-store and online retailers and make their mark on ending childhood cancer.
St. Jude have announced results of the Total Therapy Study 16 clinical trial, which tested strategies for lowering the rate of relapse of acute lymphoblastic leukemia in children from 2007–2017.
St. Jude researchers have discovered two enzymes that may have a crucial role in treating autoimmune disorders and certain cancers.
St. Jude Children’s Research Hospital online portal into pediatric cancer survivorship data debuts at the American Society of Human Genetics annual meeting.
St. Jude and the IAEA partner to raise awareness of childhood cancers, increase professional training, and support research in pediatric radiation oncology.
Douglas R. Green, Ph.D., is one of four recipients of the 2019 Wilbur Lucius Cross Medal for Alumni Achievement from the Yale Graduate School.
St. Jude launches a Paws at Play hospital dog program to help pediatric patients cope with the challenges of treatment and hospitalization.
How do stressed cells choose between survival or death? Evidence suggests the molecule DDX3X plays a role and offers a possible strategy for controlling chronic inflammation.
New NMR will allow
St. Jude researchers to study proteins, DNA, RNA and other biomolecules to better understand catastrophic diseases.
Scientists have used a 3D genome to improve understanding of gene regulation during development and disease. Read the latest.
A fresh take on the common blood disorder, b-thalassemia leads researchers to a novel therapy using rapamycin that is ready for clinical trial.
Aseem Ansari, Ph.D., will join
St. Jude Children’s Research Hospital as chair of the Department of Chemical Biology and Therapeutics.
A new study has for the first time looked at the global burden of pediatric cancer through the lens of years of affected and lost life.
St. Jude Children’s Research Hospital has found that prominent cancer risk gene BRCA2 can increase risk of non-Hodgkin lymphoma in children and adolescents.
St. Jude Children’s Research Hospital and Massachusetts General Hospital digs into the cells of origin for key medulloblastoma subtypes.
St. Jude Children’s Research Hospital scientists discovered an association between a mutation that causes a lysosomal storage disorder and fibrotic conditions, including idiopathic pulmonary fibrosis
St. Jude Children’s Research Hospital scientists reveal a crystal structure that illustrates a mechanism that powers and possibly starts DNA replication.
A new pathway called LANDO may protect against neurodegeneration in Alzheimer's disease. Learn about how inhibiting this pathway may positively affect treatment.
St. Jude scientists found that despite having few mutations, pediatric acute lymphoblastic leukemia does not escape immune detection.
This study provided the first detailed genomic and epigenomic map of the IGH-DUX4 rearrangement and suggested the principle a model for the IGH-DUX4 contribution to B-ALL.
St. Jude Children’s Research Hospital is ranked as the No. 2 pediatric cancer hospital on U.S. News & World Report’s 13th Annual “Best Children’s Hospitals” list.
The platform is the first to release prospective, comprehensive clinical whole-genome sequencing data directly from the clinic to the cloud.
Researchers found about 70 bacterial proteins that played an important role in transmission, and suggest combination vaccines to block and prevent invasive disease.
The work of
St. Jude Children’s Research Hospital will be on display at the 55th annual meeting of the American Society of Clinical Oncology in Chicago
St. Jude chosen to lead an international effort to define how flu infections early in life shape the immune response to virus.
Research shows how flu and respiratory bacteria work together to gain a foothold in the respiratory tract, and the first report of flu sticking to surface of respiratory bacteria.
St. Jude experts present pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.